Skip to the record

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 16 Aug 2026

Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.

Scope · likely financings by canton

40 likely financings · 18 Jul 2026 – 16 Aug 2026 · the feed below shows one weekZH ✕ show all cantonsMap: Natural Earth

Likely financing: Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided: Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased: No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round: A financing announcement on startupticker.ch names the company and matches this increase.

Published 10–16 Aug 2026 · canton ZH

12 capital increases · 5 shown

Capital increases published 10–16 Aug 2026
Company	Status	Nominal share capital (CHF) before → after	New shares, % of post-step shares	Announced roundnot disclosed in the SHAB	SHAB published	Source
SquaredData AGZH · Die Gesellschaft bezweckt die Erbringung von Dienstleistungen in den Bereichen Programmierung, …SHAB publication HR02-1006731145	Likely financingscore 0.92	139’007.90 → 195’839.40New shares 29.0%	29.0%	—	14 Aug 2026	SHAB publication HR02-1006731145
Resilens AGZH · Die Gesellschaft bezweckt die Entwicklung, den Betrieb und den Vertrieb digitaler Lösungen zur Analyse von …SHAB publication HR02-1006731136	Likely financingscore 0.70	100’000 → 120’000New shares 16.7%	16.7%	—	14 Aug 2026	SHAB publication HR02-1006731136
Dentaltek Research AGZH · Die Gesellschaft bezweckt Beratung, Entwicklung, Herstellung, Handel mit und Vertrieb von medizintechnischen …SHAB publication HR02-1006731057	Likely financingscore 0.72	129’522 → 152’377New shares 15.0%	15.0%	—	14 Aug 2026	SHAB publication HR02-1006731057
NovaGo Therapeutics AGZH · Die Gesellschaft bezweckt die Entwicklung von biopharmazeutischen Produkten, insbesondere im Bereich von …SHAB publication HR02-1006730162	Likely financingscore 0.95	1’115’254 → 1’346’021New shares 17.1%	17.1%	—	13 Aug 2026	SHAB publication HR02-1006730162
MUVON Therapeutics AGZH · Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb, den …SHAB publication HR02-1006730160	Likely financingscore 0.70	105’312.10 → 112’306.20New shares 6.2%	6.2%	—	13 Aug 2026	SHAB publication HR02-1006730160

7 other capital increases published this week ▸